HFE gene mutation is a risk factor for tissue iron accumulation in hemodialysis patients
Discussion: Serum iron parameters were not adequate to detect iron overload and HFE gene mutation was found to be an important risk factor for iron accumulation.
Authors: Dong ZX, Tian M, Li H, Wu Y, Du XG, Dong JW, Xiao HH, Dong LP, Song XH Abstract Objective: There is no consensus on the role of abnormal uric acid (UA) levels in the prognosis of patients undergoing hemodialysis. We therefore aimed to investigate the effects of changes in UA concentration on the risk of all-cause death and cardiac death in such patients. Method: In this retrospective cohort study, patients admitted to two hemodialysis centers performing maintenance hemodialysis (MHD) in Wuhan First Hospital and Fourth Hospital Hemodialysis Center from January 1, 2007, to October 31, 2017, were included...
Authors: Kim MS, Kim GH, Lee CH, Park JS, Lee JY, Tae K Abstract Objectives: The aim of this study was to evaluate the effectiveness of subtotal parathyroidectomy for patients with renal hyperparathyroidism. Methods: We studied 25 patients with renal hyperparathyroidism who underwent subtotal parathyroidectomy from October 2002 to October 2017. We analyzed serum intact parathyroid hormone (iPTH), calcium, and inorganic phosphorus levels before and at multiple time points following surgery, and evaluated the surgical outcomes and complications. Results: Of the 25 patients, 13 (52%) were male and 12 (48%) wer...
Publication date: Available online 21 February 2020Source: Urology Case ReportsAuthor(s): Tomotaka Yamazaki, Hiroyuki Shirai, Jun Yashima, Tamotsu TojimbaraAbstractThe patient was a 41-year-old male who had been maintained on extended-hours hemodialysis for 297 months. Despite of long-term hemodialysis vintage, he had no vascular calcification and ectopic calcification. His kidney graft did not experience rejection or other complications 18 months after the cadaveric kidney transplant. Previous reports indicated that graft survival of extended-hours hemodialysis patients did not differ from conventional hemodialysis. Howev...
CONCLUSION: In patients with ESRD undergoing dialysis, PD had lowered risks of new onset of AF compared to HD. Subsequently, these AF patients in PD group had comparable incidence of ischemic stroke but decreased incidence of hemorrhagic stroke compared to AF patients in HD group. PD could be the most suitable modality in patients at risk for the onset of AF. PMID: 32086785 [PubMed - as supplied by publisher]
Preoperative ultrasound vessel mapping is a crucial step in operative planning for permanent hemodialysis access creation. Whereas the majority of the focus remains on vein caliber, anatomic arterial variants are often overlooked. Despite being a relatively common variation, little is known about the impact of a high brachial bifurcation on hemodialysis access outcomes. Our goal was to examine the relationship between a high brachial bifurcation and arteriovenous fistula (AVF) maturation and patency in patients undergoing upper arm hemodialysis access placement.
This study investigated a wearable device that enables remote monitoring of AVF function as well as physiologic parameters. The aim of the study was to evaluate the ability of the device to assess AVF function as well as to measure hemoglobin (Hgb) and hematocrit (Hct), markers that can have an impact on dialysis fluid management.
Owing to the lack of comparative evidence between the endovascular technologies for arteriovenous fistula (AVF) stenosis treatments, we sought to summarize the reported data comparing the effectiveness of different endovascular approaches for the treatment of AVF stenoses at the juxta-anastomotic site.
To report results from the Ellipsys EndoAVF registry
Vascular access issues are an important cause of morbidity within the hemodialysis population, with significant associated health care costs related to dialysis access stenosis. Previous studies have demonstrated the beneficial role of endovascular drug coated balloon angioplasty (DCB) procedures in de novo hemodialysis access stenosis complications. However, there is limited data that directly compares the longevity of DCB and plain old balloon angioplasty (POBA) interventions in stenotic hemodialysis access lesions in patients with single preceding POBA intervention.